/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.04%
Natural Gas
-3.22%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+1.03%
VIX
N/A
Economic Calendar
EUR/USD
-0.04%
Natural Gas
-3.22%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+1.03%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Michigan Consumer Confidence Drops To 77.2 In April, Missing Analyst Expectations
about 6 hours ago
Fed Inflation Gauge Surges to 2.8% in March, Surpassing Expectations
about 6 hours ago
Bank of Japan Monetary Policy Decision Sends the USD/JPY to 156
about 16 hours ago
Tech Giants Excel: Alphabet’s Dividend, Microsoft’s AI Growth, Snap’s Q1 Surge
about 24 hours ago
Microsoft and Alphabet Bracing for Key Earnings Release
1 day ago
Pending Home Sales Increased 3.4% In March, Beating Analyst Expectations
1 day ago
Allison Transmission Shares Driven by Big Money
3 minutes ago
Vertiv Shares Climbing Due to Big Money Buyers
21 minutes ago
Tradeweb Shares Attract Big Money
24 minutes ago
Shiba Inu Price Forecast: This $23M Signal Could Drive SHIB to $0.000030
18 minutes ago
Here’s 3 Commodities Primed For Triple Digit Gains In 2024
29 minutes ago
NASDAQ Index, SP500, Dow Jones Forecasts – NASDAQ Rallies As Alphabet Gains 9.6%
about 1 hour ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
MDGL
news
Madrigal Pharmaceuticals Inc
Follow
MDGL
(
Nasdaq - US
)
N/A
193.49
-0.89 (-0.46%)
in
:
usd
•
As of: Apr 26, 2024 15:59
UTC -4
Open
192.12
High
195.12
Low
189.56
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Latest News
InvestorPlace
Apr 15, 2024
7 Stocks Analysts Are Loving Right Now (And You Should Too): April 2024
MDGL
-0.46%
NFLX
-0.65%
The Motley Fool
Apr 10, 2024
2 Under-the-Radar Growth Stocks to Consider
MDGL
-0.46%
AXSM
+0.34%
The Motley Fool
Apr 5, 2024
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
MDGL
-0.46%
VKTX
+7.93%
The Motley Fool
Apr 3, 2024
1 No-Brainer Growth Stock to Buy Now
MDGL
-0.46%
InvestorPlace
Apr 2, 2024
The 3 Best Biotech Stocks to Buy in April 2024
MDGL
-0.46%
VKTX
+7.93%
The Motley Fool
Mar 29, 2024
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals
MDGL
-0.46%
VKTX
+7.93%
The Motley Fool
Mar 29, 2024
Is This Healthcare Stock a Screaming Buy After Scoring a Huge Drug Approval?
MDGL
-0.46%
Zacks Investment Research
Mar 28, 2024
2 Top Biotech Buyout Candidates
MDGL
-0.46%
LLY
+1.09%
NVO
+0.83%
The Motley Fool
Mar 26, 2024
Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock
MDGL
-0.46%
The Motley Fool
Mar 22, 2024
This Under-the-Radar Stock Just Hit a Major Milestone: Time to Buy?
MDGL
-0.46%
The Motley Fool
Mar 19, 2024
Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?
MDGL
-0.46%
LLY
+1.09%
NVO
+0.83%
InvestorPlace
Mar 19, 2024
7 Biotech Stocks Ready to Ride the Sector's Resurgence
MDGL
-0.46%
TECH
+2.23%
Seeking Alpha
Mar 18, 2024
Madrigal: Accelerated Rezdiffra Approval Puts It In The NASH Lead
MDGL
-0.46%
The Motley Fool
Mar 17, 2024
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
MDGL
-0.46%
Zacks Investment Research
Mar 15, 2024
Madrigal (MDGL) Stock Up as FDA Approves First Drug for NASH
MDGL
-0.46%
InvestorPlace
Mar 15, 2024
MDGL Stock Alert: The Historic Reason Madrigal Is Up 19% Today
MDGL
-0.46%
CNBC
Mar 14, 2024
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
MDGL
-0.46%
Market Watch
Mar 14, 2024
Madrigal Pharmaceuticals gets first FDA approval for drug targeting liver disease MASH
MDGL
-0.46%
Investors Business Daily
Mar 14, 2024
Why Madrigal Stock, Which Has Gained 62% In A Month, Just Slumped Ahead Of A Potential First-Ever In MASH
MDGL
-0.46%
The Motley Fool
Mar 9, 2024
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.
MDGL
-0.46%
REGN
-0.91%
Stocks
Popular
Currencies
Commodities
Indices
Stocks
ETFs
Crypto
Watchlist
Loading
Loading
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker